瑞康医药 (002589.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(瑞康医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,018,758,765.188,034,367,997.336,105,062,530.674,079,932,498.772,073,027,669.1612,311,277,753.6610,896,716,818.797,551,070,413.294,093,497,042.67
 营业利润(元) 26,383,550.13-126,635,436.3951,104,126.2464,831,982.9932,977,740.71-1,716,619,257.72196,034,191.99172,085,995.96151,289,600.27
 利润总额(元) 24,410,822.11-135,417,716.3033,260,792.1667,104,416.5732,936,581.69-1,743,911,564.01184,423,810.74164,098,451.14146,001,703.08
 净利润(元) 18,571,098.8031,971,234.6227,832,019.6041,586,431.7529,983,448.04-1,739,472,653.43145,362,681.81138,001,790.9498,579,158.25
 归属于母公司股东的净利润(元) 15,168,972.6920,317,689.3519,220,119.0630,667,269.8121,159,565.23-1,831,651,850.3061,084,955.2758,990,871.5742,736,596.17
盈利能力:
 销售毛利率(%) 12.0410.2913.4113.0715.4213.5816.7917.4717.44
 销售净利率(%) 0.920.400.461.021.45-14.131.331.832.41
 净资产收益率(%) 0.280.370.310.470.33----
 总资产报酬率ROA(%) 0.46-0.020.970.920.65----
 投入资本回报率ROIC(%) 0.120.150.130.210.14-10.980.340.320.23
营运能力:
 存货周转率(次) 2.036.954.822.741.32----
 应收账款周转率(次) 0.502.041.030.610.29----
 总资产周转率(次) 0.120.460.300.190.09----
偿债能力:
 资产负债率(%) 63.6566.2667.3268.3269.8368.6264.0362.7165.20
 股东权益比率(%) 35.1132.6031.4630.0228.3329.5029.2728.8426.87
 已获利息倍数(倍) 1.44-0.021.201.501.28-3.821.661.852.38
 流动比率 1.091.071.051.071.051.031.211.261.23
 速动比率 0.970.950.970.980.970.931.081.101.07
发展能力:
 营业收入增长率(%) -2.62-34.74-43.97-45.97-49.36-41.54-38.21-40.59-28.99
 营业利润增长率(%) -20.0092.62-73.93-62.33-78.20-443.96-64.46-57.05-38.06
 税后利润增长率(%) -28.31101.11-68.54-48.01-50.49-1,496.31-51.32-48.95-47.66
 净资产增长率(%) 0.480.75-21.26-26.18-26.48-28.53-7.98-1.62-1.58
 总资产增长率(%) -18.92-8.85-26.74-29.10-30.28-30.56-17.58-12.54-14.96

前瞻产业研究院